Fanconi Anemia Cancer Screening Study
Overview
The Fanconi Anemia Screening Study seeks to improve cancer screening in people with Fanconi anemia (FA), the most common Inherited Bone Marrow Failure Syndrome (IBMFS). Visit the participant website to enroll in the study.
Background & Purpose
People with FA have an increased risk of developing cancer at young ages. The most common cancer is squamous cell carcinoma of the head and neck area particularly of the tongue and oral mucosa followed by esophagus, and anogenital region. Early detection of cancer leads to early treatment and is important to improving overall survival in people with FA.
People with FA can develop visible changes as red and white spots or other changes in their mouth that can progress to cancer. Research studies have shown that oral mouth inspection combined with non-invasive oral brushing of these visible spots in people with FA successfully detects precancerous and cancerous lesions in people with FA.
Study Team
Neelam Giri, M.D., M.B.B.S, principal investigator
Lisa J. McReynolds, M.D., Ph.D., principal investigator
Join the Study
If you're interested in joining the study, please visit the Fanconi Anemia Cancer Screening Study enrollment website, or call (240) 276-5047 for more information.